Loading…
Collecting duct renal cell carcinoma: a single centre series and review of the literature
All cases had clear Bellini duct renal cell carcinoma appearance on microscopy with infiltrative tubular architecture and high-grade nuclear features. The latter explains the use of chemotherapeutic regimens, after surgical resection if feasible, rather than tyrosine kinase inhibitor (TKI) or immuno...
Saved in:
Published in: | Central European journal of urology 2022-01, Vol.75 (3), p.252-256 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | All cases had clear Bellini duct renal cell carcinoma appearance on microscopy with infiltrative tubular architecture and high-grade nuclear features. The latter explains the use of chemotherapeutic regimens, after surgical resection if feasible, rather than tyrosine kinase inhibitor (TKI) or immunotherapy (IO) as a systemic treatment in most series [6]. All cases had clear Bellini duct renal cell carcinoma appearance on microscopy with infiltrative tubular architecture and high-grade nuclear features. There is no literature clarifying the place of cytoreductive nephrectomy in treatment of advanced CDRCC. Because of limited response to current systemic treatment, at present cytoreductive nephrectomy in conjunction to systematic treatment is suggested when feasible or for local symptom control [14]. All patients in our series had systemic treatment by means of combination chemotherapy: gem-citabine with platinum-based chemotherapy. |
---|---|
ISSN: | 2080-4873 2080-4806 2080-4873 |
DOI: | 10.5173/ceju.2022.0143 |